Volume 1, Issue 1

• New Drugs Quetiapine Sustained Release Studiedin the Treatment of Schizophrenia
  Author(s): Robert R. Conley,
  • Abstract
  • PDF
• Recovery and Schizophrenia
  Author(s): Peter F. Buckley, Gareth Fenley,Alex Mabe, Scott Peeples
  • Abstract
  • PDF
• Why Not Clozapine?
  Author(s): Deanna L. Kelly, Julie Kreyenbuhl, Robert W. Buchanan, Anil K. Malhotra
  • Abstract
  • PDF
• Differences in Protein Profiles in Schizophrenia Prefrontal Cortex Compared to Other Major Brain Disorders
  Author(s): Laura J.W. Harris, Jane E. Swatton, Martina Wengenroth,Matthew Wayland, Helen E. Lockstone, Anthony Holland,Richard L.M. Faull, Kathryn S. Lilley, Sabine Bahn
  • Abstract
  • PDF
• Comparison of Antipsychotics for Metabolic Problems (CAMP): A NIMH Schizophrenia Trials Network Study
  Author(s): T. Scott Stroup, Joseph P. McEvoy,2Marvin S. Swartz, Robert M. Hamer, Diana O. Perkins, Jeffrey A. Lieberman
  • Abstract
  • PDF
• Psychostimulant-Induced Chronic Schizophrenia-Like Disorder
  Author(s): Eric M. Pihlgren, Nash N. Boutros
  • Abstract
• Weight Loss Interventions for Patients with Schizophrenia
  Author(s): Martin Strassnig, Rohan Ganguli
  • Abstract
  • PDF
• The Efficacy and Safety of Conventional and Atypical Antipsychotics in First-Episode Schizophrenia: A Review of the Literature
  Author(s): Nina R. Schooler
  • Abstract
  • PDF
• Schizophrenia: Effect of Perceived Stigma on Two Dimensions of Recovery
  Author(s): Janet L. Landeen, Mary V. Seeman,Paula Goering, David Streiner
  • Abstract
  • PDF